It makes no sense to me the fact the company was up and about on the Covid front back in 2022, positive results would have gone along way for CTAP acceptance and probably funding options as well. The Covid trial was completed AUG 2022…….to put on hold and concentrate on the HIV? The potential for two fronts looked to be enormous Covid and HIV the fact new antiviral technologies for next pandemic preparedness was in the spotlight. Anyhow MM will have to explain herself on that front.
The Final Countdown, page-103
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
